Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1V-Fend----[1] 299 💬
2V08CA02----[1] 13 💬
3V08CA09----[1] 13 💬
4V117957----[1] 226 💬
5V1512----[1] 6 💬
6V1512 and Entacapone[1] Entacapone[1] Entacapone 💬 [1] COMT 💬 [3] Dopaminergic synapse, Steroid hormone biosynthesis, Tyrosine metabolism 💬[1] 6 💬
7V565----[2] 96, 97 💬
8V81444----[1] 6 💬
9Vaccin grippal pandémique H1N1----[1] 299 💬
10Vaccination----[1] 49 💬
11Vaccination against cholera----[1] 97 💬
12Vaccination against TBE----[1] 46 💬
13Vaccination with 2 doses of Shingrix vaccine----[2] 41, 51 💬
14Vaccination with vaccine against hepatitis A and B----[1] 299 💬
15Vaccine----[2] 49, 97 💬
16Vaccine anti-H1N1----[1] 97 💬
17Vaccine Vivotif + Vaccine Dukoral----[1] 97 💬
18Vaccine Vivotif + Vaccine Dukoral + oats----[1] 97 💬
19VACCINO CONTRO IL MEMINGOCOCCO DI GRUPPO B----[5] 61, 62, 63, 66, 223 💬
20VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON PROTEINA DIFTERICA CRM197----[1] 62 💬
21VACCINO HAEMOPHILUS INFLUENZAE B CONIUGATO CON TOSSOIDETETANICO----[5] 61, 62, 63, 66, 223 💬
22VACCINO MENINGOCOCCICO POLISACCARIDICO----[1] 62 💬
23VACCINO PNEUMOCOCCICO----[2] 62, 66 💬
24VACCINO PNEUMOCOCCICO SACCARIDICO----[1] 14 💬
25VACCINO POLISACCARIDICO ANTI-MENINGOCOCCICO (A.C.Y E W-135)----[5] 61, 62, 63, 66, 223 💬
26VAD044[1] VAD-044---[1] 227 💬
27VAD044 Part I[1] VAD-044---[1] 227 💬
28VAD044 Part II[1] VAD-044---[1] 227 💬
29Vaginal estriol[1] Estriol[2] Estriol ,
Estriol tripropionate 💬 		[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 13 💬
30Vaginal estrogen----[1] 226 💬
31VAL-1221----[2] 256, 309 💬
32Valbenazine[1] Valbenazine[2] Valbenazine ,
Valbenazine tosylate 💬 		[1] SLC18A2 💬 [8] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Neuroactive ligand signaling, Parkinson disease, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 8 💬
33Valdecoxib[1] Valdecoxib---[1] 46 💬
34Valerian[1] Valerian---[1] 6 💬
35Valganciclovir[1] Valganciclovir[2] Valganciclovir ,
Valganciclovir hydrochloride 💬 		--[6] 28, 60, 85, 97, 299, 331 💬
36Valganciclovir (VGC)[1] Valganciclovir[2] Valganciclovir ,
Valganciclovir hydrochloride 💬 		--[1] 331 💬
37Valganciclovir [Valcyte][1] Valganciclovir[2] Valganciclovir ,
Valganciclovir hydrochloride 💬 		--[1] 299 💬
38Valiloxybate----[1] 6 💬
39Valine[1] Valine[1] Valine 💬 --[1] 244 💬
40Valine oral solution (50mg/ml) and isoleucine oral solution (25mg/ml)[2] Isoleucine,
Valine		[2] Valine ,
Isoleucine 💬 		--[1] 244 💬
41VALPROATE SODIUM[1] Valproic acid[3] Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		[16] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
42Valproate, Levocarnitine[1] Levocarnitine[2] Levocarnitine chloride ,
Levocarnitine 💬 		--[1] 3 💬
43Valproic Acid[1] Valproic acid[3] Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		[16] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[10] 3, 5, 26, 34, 65, 89, 90, 145, 222, 331 💬
44Valproic Acid (VPA)[1] Valproic acid[3] Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		[16] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
45Valproic Acid and Levocarnitine[2] Levocarnitine,
Valproic acid		[5] Divalproex sodium ,
Valproic acid ,
Valproate sodium ,
Levocarnitine chloride ,
Levocarnitine 💬 		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		[16] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
46Valproid acid plus corticosteroids----[1] 26 💬
47Valsacor----[2] 167, 168 💬
48Valsartan[1] Valsartan[1] Valsartan 💬 [1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[11] 28, 57, 58, 66, 75, 86, 210, 218, 222, 223, 224 💬
49Valsartan (VAL489)[1] Valsartan[1] Valsartan 💬 [1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 222 💬
50Valsartan 40 mg[1] Valsartan[1] Valsartan 💬 [1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 86 💬
51Valsartan capsule[1] Valsartan[1] Valsartan 💬 [1] AGTR1 💬 [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 223 💬
52Valsartanum 40 mg / Placebo 1----[2] 167, 168 💬
53Valsartanum 80 mg / Placebo 2----[2] 167, 168 💬
54Valzek----[2] 167, 168 💬
55Vamarolone----[1] 113 💬
56Vaminolac----[1] 97 💬
57Vaminolac, komb.----[1] 97 💬
58Vamorolone[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[2] 97, 113 💬
59Vamorolone 0.25 mg/day/day[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
60Vamorolone 0.25 mg/kg/day[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
61Vamorolone 0.75 mg/day/day[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
62Vamorolone 0.75 mg/kg/day[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
63Vamorolone 2.0 mg/day/day[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
64Vamorolone 2.0 mg/kg/day[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
65Vamorolone 4% suspension for oral dosing[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 97 💬
66Vamorolone 40 mg/mL oral suspension[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
67Vamorolone 6.0 mg/day/day[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
68Vamorolone 6.0 mg/kg/day[1] Vamorolone[1] Vamorolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 113 💬
69Vanakizumab----[1] 40 💬
70VANCOMICINA CLORIDRATO----[2] 94, 97 💬
71Vancomycin[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[9] 6, 13, 46, 70, 94, 96, 97, 296, 299 💬
72Vancomycin (blinded)[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[2] 94, 97 💬
73Vancomycin (open-label extension)[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[2] 94, 97 💬
74Vancomycin (POC)[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[1] 97 💬
75Vancomycin /Amphotericin B (Fungizone®) /Gentamicine 80 mg[2] Amphotericin B,
Vancomycin		[3] Amphotericin B ,
Vancomycin ,
Vancomycin hydrochloride 💬 		--[2] 96, 97 💬
76Vancomycin hydrochloride inhalation powder[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[1] 299 💬
77Vancomycin inhalation powder[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[1] 299 💬
78Vancomycin Oral Capsule[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[1] 97 💬
79Vancomycin Pre-Treat[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[1] 97 💬
80Vancomycin Pre-Treatment[1] Vancomycin[2] Vancomycin ,
Vancomycin hydrochloride 💬 		--[1] 97 💬
81Vancomycin, mupirocin ointment[2] Mupirocin,
Vancomycin		[4] Vancomycin ,
Vancomycin hydrochloride ,
Mupirocin ,
Mupirocin calcium 💬 		--[1] 97 💬
82Vantobra (tobramycin)[1] Tobramycin[2] Tobramycin ,
Tobramycin sulfate 💬 		--[1] 299 💬
83Vanzacaftor[1] Vanzacaftor[2] Vanzacaftor ,
Vanzacaftor calcium 💬 		[1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
84Vardenafil[1] Vardenafil[2] Vardenafil ,
Vardenafil hydrochloride 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[3] 13, 86, 299 💬
85Vardenafil (hidrocloride)[1] Vardenafil[2] Vardenafil ,
Vardenafil hydrochloride 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[1] 13 💬
86VARDENAFILO HIDROCLORURO[1] Vardenafil[2] Vardenafil ,
Vardenafil hydrochloride 💬 		[1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[1] 13 💬
87VARENICLINE[1] Varenicline[2] Varenicline tartrate ,
Varenicline 💬 		[2] CHRNA4,
CHRNB2 💬 		[5] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[4] 6, 18, 53, 298 💬
88Varenicline Nasal Spray[1] Varenicline[2] Varenicline tartrate ,
Varenicline 💬 		[2] CHRNA4,
CHRNB2 💬 		[5] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[1] 53 💬
89VARENICLINE TARTRATE[1] Varenicline[2] Varenicline tartrate ,
Varenicline 💬 		[2] CHRNA4,
CHRNB2 💬 		[5] Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction 💬[1] 6 💬
90VARI----[2] 62, 274 💬
91Variation of behaviors of Parkinson's disease----[1] 6 💬
92Varicella Zoster Vaccine----[1] 46 💬
93Various----[1] 95 💬
94Vaseline----[1] 51 💬
95Vasodilator-based PAH therapy----[1] 86 💬
96Vasomera[1] Vasomera---[1] 86 💬
97Vasomera (PB1046) Injection[1] Vasomera---[1] 86 💬
98Vasopressin[1] Vasopressin[1] Vasopressin 💬 [3] AVPR1A,
AVPR1B,
AVPR2 💬 		[6] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[2] 210, 225 💬
99Vasopressin, Arginine[2] Arginine,
Vasopressin		[4] Vasopressin ,
Arginine hydrochloride ,
Arginine ,
Arginine hydrochloride 💬 		[3] AVPR1A,
AVPR1B,
AVPR2 💬 		[6] Calcium signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption 💬[1] 210 💬
100Vastarel----[2] 2, 58 💬
101Vastarel 20mg film coated tablets----[1] 58 💬
102Vatelizumab[1] Vatelizumab---[2] 13, 97 💬
103VATIQUINONE[1] Vatiquinone[1] Vatiquinone 💬 --[2] 18, 21 💬
104Vaxzevria----[1] 299 💬
105Vaxzevria suspension for injection COVID-19 Vaccine (ChAdOx1-S----[1] 299 💬
106VAY736----[9] 13, 35, 46, 49, 53, 61, 63, 85, 95 💬
107VAY736 1ml PFS----[2] 46, 49 💬
108VAY736 2 ml PFS----[2] 46, 49 💬
109VAY736 2ml AI----[2] 46, 49 💬
110VAY736 antibody----[1] 53 💬
111VAY736 higher dose----[1] 53 💬
112VAY736 lower dose----[1] 53 💬
113VB-201[1] VB-201---[1] 97 💬
114VB-201 160mg[1] VB-201---[1] 97 💬
115VB119----[1] 222 💬
116VB13S1----[1] 13 💬
117VB5S2----[1] 13 💬
118VB6S5----[1] 13 💬
119VBP15----[1] 113 💬
120VC005 tablets----[2] 46, 271 💬
121VCA-894A[1] VCA-894A---[1] 10 💬
122VE202----[1] 97 💬
123Vector viral adenoasociado de serotipo 9 que contiene el gen de la sulfamidasa humana----[1] 19 💬
124VEDOLIZUMAB[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[3] 94, 96, 97 💬
125Vedolizumab (Genetical Recombination)[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
126Vedolizumab (VDZ)[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
127Vedolizumab 108 mg SC[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
128Vedolizumab 300 mg[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
129Vedolizumab 300 MG Injection [Entyvio][1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
130Vedolizumab 300 mg IV[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
131Vedolizumab Injection[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 97 💬
132Vedolizumab intravenous injection[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
133Vedolizumab IV[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[3] 94, 96, 97 💬
134Vedolizumab IV (Entyvio¿)[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
135Vedolizumab IV (Entyvio™)[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
136Vedolizumab IV 300 mg[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
137Vedolizumab SC[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
138Vedolizumab SC 108 mg[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[1] 96 💬
139Vedolizumab subcutaneous injection[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
140Vedolizumab, Entyvio[1] Vedolizumab[1] Vedolizumab 💬 [2] ITGA4,
ITGB7 💬 		[18] Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecule (CAM) interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection 💬[2] 96, 97 💬
141Vedolizumab, Ustekinumab, or Tofacitinib[3] Tofacitinib,
Ustekinumab,
Vedolizumab		[4] Vedolizumab ,
Ustekinumab ,
Tofacitinib citrate ,
Tofacitinib 💬 		[9] IL12A,
IL12B,
IL23A,
ITGA4,
ITGB7,
JAK1,
JAK2,
JAK3,
TYK2 💬 		[69] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cell adhesion molecule (CAM) interaction, Chagas disease, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytoskeleton in muscle cells, Dilated cardiomyopathy, ECM-receptor interaction, Efferocytosis, Epstein-Barr virus infection, Focal adhesion, Growth hormone synthesis, secretion and action, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IgSF CAM signaling, Inflammatory bowel disease, Influenza A, Integrin signaling, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, Malaria, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pertussis, Primary immunodeficiency, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Yersinia infection 💬[1] 97 💬
142VEDROP----[1] 299 💬
143VEDULIZUMAB----[1] 97 💬
144Vegan drink----[1] 97 💬
145Vegetarian meat alternative----[1] 97 💬
146Vegetarian yogurt----[1] 97 💬
147Vehice Control----[1] 96 💬
148Vehicle----[5] 6, 36, 53, 160, 192 💬
149Vehicle (SD-101 0%)----[1] 36 💬
150Vehicle Control----[1] 53 💬
151Vehicle Cream----[1] 36 💬
152Vehicle eye drops----[1] 90 💬
153Vehicle Gel----[2] 13, 34 💬
154Vehicle of ADX-102 Topical Dermal Cream----[1] 160 💬
155Vehicle ophthalmic solution----[1] 53 💬
156Vehicle Topical Gel----[1] 36 💬
157VELAGLUCERASE ALFA[1] Velaglucerase alfa[1] Velaglucerase alfa 💬 [1] GBA1 💬 [4] Cornified envelope formation, Lysosome biogenesis, Other glycan degradation, Sphingolipid metabolism 💬[1] 19 💬
158Velaglucerasi alfa----[1] 19 💬
159Velamox----[1] 11 💬
160VELCADE----[1] 28 💬
161VELCADE*1FL 3,5MG----[1] 28 💬
162VELCADE*EV 1FL 3,5MG 1MG/ML----[1] 61 💬
163Velcade®----[1] 11 💬
164Veldona,----[1] 56 💬
165Veledimex[1] Veledimex[1] Veledimex 💬 --[1] 51 💬
166VELMANASE ALFA[1] Velmanase alfa[1] Velmanase alfa 💬 [1] MAN2B1 💬 [2] Lysosome biogenesis, Other glycan degradation 💬[1] 19 💬
167Velmanase Alfa (e.g. Lamazym)[1] Velmanase alfa[1] Velmanase alfa 💬 [1] MAN2B1 💬 [2] Lysosome biogenesis, Other glycan degradation 💬[1] 19 💬
168Velsipity----[1] 97 💬
169Veltuzumab[1] Veltuzumab[1] Veltuzumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[2] 46, 63 💬
170Veltuzumab solution 75mg/ml[1] Veltuzumab[1] Veltuzumab 💬 [1] MS4A1 💬 [1] Hematopoietic cell lineage 💬[1] 46 💬
171Velusetrag[1] Velusetrag[1] Velusetrag 💬 [1] HTR4 💬 [5] Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬[1] 99 💬
172Velusetrag 15 mg once daily for 4 weeks.[1] Velusetrag[1] Velusetrag 💬 [1] HTR4 💬 [5] Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬[1] 99 💬
173Venetoclax[1] Venetoclax[1] Venetoclax 💬 [1] BCL2 💬 [40] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[2] 28, 85 💬
174Venetoclax MTD with Dexamethasone[2] Dexamethasone,
Venetoclax		[4] Dexamethasone ,
Dexamethasone sodium phosphate ,
Dexamethasone phosphate ,
Venetoclax 💬 		[2] BCL2,
NR3C1 💬 		[41] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neuroactive ligand-receptor interaction, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬
175Venetoclax Oral Tablet, 200 mg[1] Venetoclax[1] Venetoclax 💬 [1] BCL2 💬 [40] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬
176Venetoclax Oral Tablet, 400 mg[1] Venetoclax[1] Venetoclax 💬 [1] BCL2 💬 [40] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Amyotrophic lateral sclerosis, Apoptosis, Apoptosis - multiple species, Autophagy - animal, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Colorectal cancer, Epstein-Barr virus infection, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, HIF-1 signaling pathway, Hedgehog signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human immunodeficiency virus 1 infection, JAK-STAT signaling pathway, Lipid and atherosclerosis, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Prostate cancer, Protein processing in endoplasmic reticulum, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, Toxoplasmosis, Tuberculosis, p53 signaling pathway 💬[1] 28 💬
177Venglustat[1] Venglustat[2] Venglustat ,
Venglustat malate 💬 		[1] UGCG 💬 [2] Cornified envelope formation, Sphingolipid metabolism 💬[3] 6, 19, 67 💬
178Venglustat (GZ402671)[1] Venglustat[2] Venglustat ,
Venglustat malate 💬 		[1] UGCG 💬 [2] Cornified envelope formation, Sphingolipid metabolism 💬[1] 19 💬
179Venglustat GZ/SAR402671[1] Venglustat[2] Venglustat ,
Venglustat malate 💬 		[1] UGCG 💬 [2] Cornified envelope formation, Sphingolipid metabolism 💬[2] 6, 67 💬
180Venglustat GZ402671[1] Venglustat[2] Venglustat ,
Venglustat malate 💬 		[1] UGCG 💬 [2] Cornified envelope formation, Sphingolipid metabolism 💬[2] 19, 67 💬
181Venglustat L-malate[1] Venglustat[2] Venglustat ,
Venglustat malate 💬 		[1] UGCG 💬 [2] Cornified envelope formation, Sphingolipid metabolism 💬[1] 19 💬
182Venglustat malate[1] Venglustat[2] Venglustat ,
Venglustat malate 💬 		[1] UGCG 💬 [2] Cornified envelope formation, Sphingolipid metabolism 💬[3] 6, 19, 67 💬
183Venglustat malato[1] Venglustat[2] Venglustat ,
Venglustat malate 💬 		[1] UGCG 💬 [2] Cornified envelope formation, Sphingolipid metabolism 💬[2] 19, 67 💬
184VenglustatProduct Code: SAR402671, GZ402671 or GZ / SAR402671Pharmaceutical Form: TabletINN or Proposed INN: Venglustat malateCAS Number: 1629063-78-0Current Sponsor code: GZ402671Other descriptive name: GZ/SAR402671Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 6-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral useProduct Name: venglustatProduct Code: SAR402671, GZ402671 or GZ / SAR402671Pharmaceutical Form: TabletINN or Proposed INN: Venglustat malateCAS Number: 1629063-78-0Current Sponsor code: GZ402671Other descriptive name: GZ/SAR402671Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 15-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral use[1] Venglustat[2] Venglustat ,
Venglustat malate 💬 		[1] UGCG 💬 [2] Cornified envelope formation, Sphingolipid metabolism 💬[1] 19 💬
185Venipunctures----[1] 84 💬
186VENITAL - 50 G/L SOLUZIONE PER INFUSIONE FLACONCINO DA 100 ML + SET INFUSIONALE----[1] 309 💬
187Venlafaxin Hexal----[1] 13 💬
188Venlafaxine[1] Venlafaxine[3] Venlafaxine hydrochloride ,
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		[2] SLC6A2,
SLC6A4 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[4] 6, 13, 46, 97 💬
189Venlafaxine extended-release (XR)[1] Venlafaxine[3] Venlafaxine hydrochloride ,
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		[2] SLC6A2,
SLC6A4 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 46 💬
190VENLAFAXINE HYDROCHLORIDE[1] Venlafaxine[3] Venlafaxine hydrochloride ,
Venlafaxine ,
Venlafaxine besylate monohydrate 💬 		[2] SLC6A2,
SLC6A4 💬 		[3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[2] 13, 46 💬
191Venofer----[1] 97 💬
192Venofer solution for injection, 100 mg iron----[1] 97 💬
193Venofer solution for injection, 20 mg iron/ml----[1] 97 💬
194Venofer solution for injection, 20 mg/ml iron----[1] 97 💬
195Venous blood sample----[1] 46 💬
196Venous blood sample of 20ml----[1] 6 💬
197Venous blood samples, anal swab samples, vaginal swab samples, high resolution anoscopy (HRA), anal biopsy samples----[2] 96, 97 💬
198VENT-02----[1] 6 💬
199VENT-03----[1] 49 💬
200Ventavis----[1] 86 💬
201Ventavis (Iloprost, BAYQ6256)[1] Iloprost[2] Iloprost ,
Iloprost tromethamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
202Ventavis 10----[1] 86 💬
203Ventavis(Iloprost)[1] Iloprost[2] Iloprost ,
Iloprost tromethamine 💬 		[1] PTGIR 💬 [3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86 💬
204Ventolin----[1] 299 💬
205Ventoline oral solution 0,4mg/ml----[1] 111 💬
206Ventoline tablet 2mg----[1] 111 💬
207Ventolin® Evohaler----[1] 299 💬
208Ventolin¿ Evohaler¿----[1] 299 💬
209Ventrix Bio Extracellular Matrix----[1] 211 💬
210Venus Versa----[1] 265 💬
211Verapamil[1] Verapamil[2] Verapamil hydrochloride ,
Verapamil 💬 		[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[5] 57, 58, 96, 140, 167 💬
212VERAPAMIL HYDROCHLORIDE[1] Verapamil[2] Verapamil hydrochloride ,
Verapamil 💬 		[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58 💬
213Verapamil SR[1] Verapamil[2] Verapamil hydrochloride ,
Verapamil 💬 		[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 167 💬
214Verapamil tablet[1] Verapamil[2] Verapamil hydrochloride ,
Verapamil 💬 		[4] CACNA1C,
CACNA1D,
CACNA1F,
CACNA1S 💬 		[37] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 58 💬
215Verde de Indocianina (Indocyanine Green)[2] Indocyanine green,
Indocyanine green acid form		[1] Indocyanine green 💬 --[1] 235 💬
216Verdiperstat[1] Verdiperstat[1] Verdiperstat 💬 [1] MPO 💬 [5] Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagocytosis, Transcriptional misregulation in cancer 💬[3] 2, 17, 127 💬
217VEREGEN(R)----[1] 160 💬
218Verenafusp alfa 12 mg/kg----[1] 19 💬
219Verenafusp alfa 6 mg/kg----[1] 19 💬
220Verenafusp alfa 9 mg/kg----[1] 19 💬
221Vericiguat[1] Vericiguat[1] Vericiguat 💬 [3] GUCY1A1,
GUCY1A2,
GUCY1B1 💬 		[10] Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 58, 86 💬
222Verorab® (PVRV----[1] 65 💬
223Verum arm receiving Gilenya®----[1] 13 💬
224Verum arm receiving Vitamin D oil[1] Vitamin D---[1] 13 💬
225VERVE-101----[1] 79 💬
226VERVE-102----[1] 79 💬
227VES001----[1] 127 💬
228VESANOID----[1] 75 💬
229Vesemnogene lantuparvovec----[1] 3 💬
230VESIcare 10Mg Tablet----[1] 13 💬
231Vesleteplirsen[1] Vesleteplirsen---[1] 113 💬
232Vestronidase alfa[1] Vestronidase alfa[1] Vestronidase alfa 💬 [1] GUSB 💬 [6] Ascorbate and aldarate metabolism, Drug metabolism - other enzymes, Glycosaminoglycan degradation, Lysosome biogenesis, Pentose and glucuronate interconversions, Porphyrin metabolism 💬[1] 19 💬
233Vett Lentiviral con gene ABCA4----[1] 301 💬
234Vfend----[1] 299 💬
235VFEND 40 mg/ml powder for oral suspension----[1] 299 💬
236VG801----[1] 301 💬
237VG901----[1] 90 💬
238VGB-ST----[1] 145 💬
239VGB-ST soluble tablets----[1] 145 💬
240VGN-R08b----[1] 19 💬
241VGN-R08b 1.68×10^14 vg----[1] 6 💬
242VGN-R08b 4.2×10^13 vg----[1] 6 💬
243VGN-R08b 8.4×10^13 vg----[1] 6 💬
244VGN-R09b----[1] 6 💬
245VGN-R13----[1] 2 💬
246VHB937----[1] 2 💬
247VI-0106----[1] 86 💬
248VIAGRA----[3] 86, 96, 225 💬
249VIALEBEX----[1] 96 💬
250Vialebex 200mg----[1] 96 💬
251Viaskin Milk 500 mcg----[1] 98 💬
252VIB0551----[1] 13 💬
253VIB4920----[2] 46, 53 💬
254VIB4920 with TNFi----[1] 46 💬
255VIB4920 without TNFi----[1] 46 💬
256VIB7734----[4] 49, 50, 51, 53 💬
257VIB7734, MEDI7734----[1] 49 💬
258Vibrox----[1] 167 💬
259Vibrox 100mg Capsules----[1] 167 💬
260Video game therapy----[1] 13 💬
261Videofluoroscopic Swallowing Study----[1] 2 💬
262Videofluoroscopic Swallowing Study (VFSS)----[1] 2 💬
263Vidofludimus[1] Vidofludimus[2] Vidofludimus ,
Vidofludimus calcium 💬 		[1] DHODH 💬 [1] Pyrimidine metabolism 💬[5] 13, 46, 94, 96, 97 💬
264VIDOFLUDIMUS CALCIUM[2] Calcium,
Vidofludimus		[2] Vidofludimus ,
Vidofludimus calcium 💬 		[1] DHODH 💬 [1] Pyrimidine metabolism 💬[4] 13, 94, 96, 97 💬
265Vidofludimus calcium dihydrate[2] Calcium,
Vidofludimus		[2] Vidofludimus ,
Vidofludimus calcium 💬 		[1] DHODH 💬 [1] Pyrimidine metabolism 💬[1] 97 💬
266VIGABATRIN[1] Vigabatrin[1] Vigabatrin 💬 [1] ABAT 💬 [6] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[2] 145, 158 💬
267Vigabatrin (Sabril)[1] Vigabatrin[1] Vigabatrin 💬 [1] ABAT 💬 [6] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 158 💬
268Vigabatrin Tablets[1] Vigabatrin[1] Vigabatrin 💬 [1] ABAT 💬 [6] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬
269Vigabatrin, oral[1] Vigabatrin[1] Vigabatrin 💬 [1] ABAT 💬 [6] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬
270Vigabatrin: Vigabatrin new ST formulation then Sabril®[1] Vigabatrin[1] Vigabatrin 💬 [1] ABAT 💬 [6] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 145 💬
271Vigantol----[2] 13, 65 💬
272Vigantol Oel----[3] 13, 96, 97 💬
273Vigantol Oel TM----[2] 96, 97 💬
274VIGANTOL OIL----[1] 13 💬
275VigantOL oil plus interferon beta-1a (Rebif)[1] Interferon beta-1a[1] Interferon beta-1a 💬 [2] IFNAR1,
IFNAR2 💬 		[18] Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13 💬
276VigantolProduct Name: VigantolPharmaceutical Form: Oral dropsTrade Name: VigantolProduct Name: VigantolPharmaceutical Form: Oral drops----[1] 299 💬
277Vigantol® Oil----[1] 13 💬
278Vigantol® Öl 20.000 I.E./ml----[1] 13 💬
279Vilamakitug[1] Vilamakitug[1] Vilamakitug 💬 [1] IL1A 💬 [21] AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬[1] 271 💬
280Vildagliptin[1] Vildagliptin[1] Vildagliptin 💬 [1] DPP4 💬 [2] Protein digestion and absorption, Virion - Hepatitis viruses 💬[1] 6 💬
281Vildagliptin 50 mg bid[1] Vildagliptin[1] Vildagliptin 💬 [1] DPP4 💬 [2] Protein digestion and absorption, Virion - Hepatitis viruses 💬[1] 6 💬
282Vilobelimab[1] Vilobelimab[1] Vilobelimab 💬 [1] C5 💬 [11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬[3] 43, 44, 269 💬
283Viltepso----[1] 113 💬
284VILTOLARSEN[1] Viltolarsen[1] Viltolarsen 💬 [1] DMD 💬 [5] Arrhythmogenic right ventricular cardiomyopathy, Cytoskeleton in muscle cells, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis 💬[1] 113 💬
285Vimizim® (elosulfase alfa)[1] Elosulfase alfa[1] Elosulfase alfa 💬 [1] GALNS 💬 [2] Glycosaminoglycan degradation, Lysosome biogenesis 💬[1] 19 💬
286VIMOVO 250/20----[1] 107 💬
287VIMOVO 375/20----[1] 107 💬
288VIMOVO 500/20----[1] 107 💬
289Vinblastine[1] Vinblastine[2] Vinblastine sulfate ,
Vinblastine 💬 		[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[3] 34, 63, 65 💬
290Vinblastine sulfate[1] Vinblastine[2] Vinblastine sulfate ,
Vinblastine 💬 		[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 34 💬
291VINBLASTINE SULPHATE[1] Vinblastine[2] Vinblastine sulfate ,
Vinblastine 💬 		[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 34 💬
292Vinblastine, vincristine, prednisone, daunorubicin[4] Daunorubicin,
Prednisone,
Vinblastine,
Vincristine		[8] Prednisone ,
Vinblastine sulfate ,
Daunorubicin hydrochloride ,
Vincristine sulfate ,
Daunorubicin ,
Vinblastine ,
Vincristine ,
Daunorubicin citrate 💬 		[10] NR3C1,
TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[13] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Neuroactive ligand-receptor interaction, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 65 💬
293Vincristine[1] Vincristine[2] Vincristine sulfate ,
Vincristine 💬 		[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[5] 26, 34, 63, 65, 331 💬
294Vincristine Sulfate[1] Vincristine[2] Vincristine sulfate ,
Vincristine 💬 		[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[2] 26, 34 💬
295Vincristine Sulfate (Oncovin)[1] Vincristine[2] Vincristine sulfate ,
Vincristine 💬 		[9] TUBB,
TUBB1,
TUBB2A,
TUBB2B,
TUBB3,
TUBB4A,
TUBB4B,
TUBB6,
TUBB8 💬 		[12] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬[1] 34 💬
296ViNeuro----[1] 6 💬
297Vinpocetine[1] Vinpocetine[1] Vinpocetine 💬 --[1] 6 💬
298VIOKASE 16----[1] 298 💬
299Viokase 16 (pancrelipase) + Nexium[1] Pancrelipase[2] Pancreatin ,
Pancrelipase 💬 		--[1] 298 💬
300Viokase® 16----[1] 298 💬
301VIP----[3] 49, 51, 86 💬
302Viral load driven treatment interruption----[1] 265 💬
303VIREAD - 245 MG 30 COMPRESSE RIVESTITE CON FILM IN FLACONE USO ORALE----[1] 46 💬
304VIREAD 30 CPR 245 MG----[1] 46 💬
305Virtual Balance Training----[1] 149 💬
306Virtual reality----[1] 149 💬
307VIS171----[2] 49, 222 💬
308VIS649----[1] 66 💬
309Viscous/swallowed budesonide[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
310Visilizumab[1] Visilizumab[1] Visilizumab 💬 [3] CD3D,
CD3E,
CD3G 💬 		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[2] 96, 97 💬
311Visilizumab (HuM291[1] Visilizumab[1] Visilizumab 💬 [3] CD3D,
CD3E,
CD3G 💬 		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 97 💬
312Visilizumab (Nuvion)[1] Visilizumab[1] Visilizumab 💬 [3] CD3D,
CD3E,
CD3G 💬 		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 97 💬
313Visilizumab (Nuvion®[1] Visilizumab[1] Visilizumab 💬 [3] CD3D,
CD3E,
CD3G 💬 		[11] Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬[1] 97 💬
314VISMODEGIB[1] Vismodegib[1] Vismodegib 💬 [1] SMO 💬 [5] Axon guidance, Basal cell carcinoma, Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer 💬[1] 85 💬
315Visual Biofeedback Therapy----[1] 6 💬
316Visual Evoked Potential (VEP)----[1] 13 💬
317Visual field testing----[1] 19 💬
318Vit C Vit E Zn Se----[1] 113 💬
319VIT D----[2] 63, 227 💬
320Vit-45----[1] 97 💬
321Vitamin A[1] Vitamin A[2] Vitamin A oil ,
Vitamin A 💬 		[2] RARA,
RARB 💬 		[8] Acute myeloid leukemia, Estrogen signaling pathway, Gastric cancer, Non-small cell lung cancer, Pathways in cancer, Small cell lung cancer, Th17 cell differentiation, Transcriptional misregulation in cancer 💬[4] 13, 53, 90, 97 💬
322Vitamin AD sig: 1 tablet/tid----[1] 90 💬
323Vitamin B 6----[1] 234 💬
324Vitamin B sig: 10mg/tid----[1] 90 💬
325Vitamin B12----[2] 6, 201 💬
326Vitamin B12 Supplementation----[1] 6 💬
327Vitamin B12, B9, B6, C supplementation----[1] 229 💬
328Vitamin B2[1] Riboflavin[1] Riboflavin 💬 --[1] 97 💬
329Vitamin B3----[1] 107 💬
330Vitamin B5 Tablets----[1] 97 💬
331Vitamin B6 25 MG----[1] 6 💬
332Vitamin B6 Tablets----[1] 97 💬
333Vitamin B7[1] Biotin[1] Biotin 💬 --[1] 8 💬
334Vitamin C----[5] 49, 206, 210, 211, 212 💬
335Vitamin D[1] Vitamin D---[26] 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
336Vitamin D (Cholecalciferol )[2] Cholecalciferol,
Vitamin D		[1] Cholecalciferol 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[2] 96, 97 💬
337Vitamin D 100ug[1] Vitamin D---[1] 298 💬
338Vitamin D 10ug[1] Vitamin D---[1] 298 💬
339Vitamin D 2[1] Vitamin D---[1] 46 💬
340Vitamin D 25(OH)D[1] Vitamin D---[1] 49 💬
341Vitamin D drops[1] Vitamin D---[2] 96, 97 💬
342Vitamin D enriched milk[1] Vitamin D---[1] 97 💬
343Vitamin D in arm B[1] Vitamin D---[1] 46 💬
344Vitamin D Oil[1] Vitamin D---[1] 299 💬
345Vitamin D Powder[1] Vitamin D---[1] 299 💬
346Vitamin D-3[1] Vitamin D---[1] 97 💬
347Vitamin D2 ( calciferol )----[1] 49 💬
348Vitamin D3----[12] 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
349Vitamin D3 (Cholecalciferol)[1] Cholecalciferol[1] Cholecalciferol 💬 [1] VDR 💬 [5] Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬[2] 96, 97 💬
350Vitamin D3 - high dose----[1] 6 💬
351Vitamin D3 3000 UI daily----[1] 96 💬
352Vitamin D3 400 IU----[1] 49 💬
353Vitamin D3 4000 UI daily----[1] 96 💬
354Vitamin D3 6000 IU----[1] 49 💬
355Vitamin D3 800 UI/day then 800 UI/day----[1] 96 💬
356Vitamin D3 capsule----[1] 6 💬
357Vitamin D3: 3000 or 4000 UI/day then 2,000 UI/day----[1] 96 💬
358Vitamin E[1] Vitamin E[1] Vitamin E 💬 --[12] 2, 6, 13, 19, 20, 46, 90, 96, 97, 206, 299, 317 💬
359VITAMIN E - TGPS[1] Vitamin E[1] Vitamin E 💬 --[1] 299 💬
360Vitamin E 800IU[1] Vitamin E[1] Vitamin E 💬 --[2] 96, 97 💬
361Vitamin E supplement[1] Vitamin E[1] Vitamin E 💬 --[1] 317 💬
362Vitamin E/Selenium[2] Selenium,
Vitamin E		[1] Vitamin E 💬 --[1] 13 💬
363Vitamin K----[1] 46 💬
364Vitamin K 10 mg----[2] 96, 97 💬
365Vitamin K 2----[1] 222 💬
366Vitamin K antagonist high intensity----[1] 48 💬
367Vitamin K antagonist standard intensity----[1] 48 💬
368Vitamin K supplementation, dose #1----[1] 299 💬
369Vitamin K supplementation, dose #2----[1] 299 💬
370Vitamin K1 Tablets----[1] 46 💬
371Vitamin: Choline Bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1[1] Choline[1] Choline 💬 --[1] 299 💬
372Vitamina A----[1] 28 💬
373VITAMINA D3 KERN PHARMA SOLUCIÓN OLEOSA----[1] 13 💬
374Vitamins: B6, B12, and folate----[1] 49 💬
375VIUSID/ALZER----[1] 6 💬
376Vivaglobin----[2] 14, 65 💬
377ViviGen Cellular Bone Matrix----[1] 70 💬
378Vivitrol Injectable Product----[1] 13 💬
379Vivomixx probiotics----[1] 51 💬
380Vivomixx®----[1] 13 💬
381Vixarelimab[1] Vixarelimab[1] Vixarelimab 💬 [1] OSMR 💬 [3] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, PI3K-Akt signaling pathway 💬[3] 51, 85, 97 💬
382Vizamyl----[3] 5, 7, 127 💬
383Vizamyl (flutemetamol(F-18))[1] Flutemetamol---[3] 5, 7, 127 💬
384VK0214[1] VK-0214---[1] 20 💬
385VKA----[1] 48 💬
386VM106----[1] 65 💬
387VM202----[1] 2 💬
388VNX001----[1] 226 💬
389VNZ/TEZ/D-IVA----[1] 299 💬
390VO4CX----[1] 296 💬
391VO659[1] VO659---[2] 8, 18 💬
392Vobarilizumab[1] Vobarilizumab[1] Vobarilizumab 💬 --[1] 49 💬
393Voclosporin[1] Voclosporin[1] Voclosporin 💬 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬 		[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[2] 49, 222 💬
394Voiding diary----[1] 226 💬
395Volanesorsen[1] Volanesorsen[2] Volanesorsen ,
Volanesorsen sodium 💬 		[1] APOC3 💬 [2] Cholesterol metabolism, PPAR signaling pathway 💬[1] 265 💬
396VOLANESORSEN SODIUM, ApoC-III Antisense Oligonucleotide[1] Volanesorsen[2] Volanesorsen ,
Volanesorsen sodium 💬 		[1] APOC3 💬 [2] Cholesterol metabolism, PPAR signaling pathway 💬[1] 265 💬
397Volibris----[4] 51, 85, 86, 88 💬
398VOLIBRIS 10 mg comprimidos recubiertos con película----[1] 86 💬
399VOLIBRIS 5 mg comprimidos recubiertos con película----[1] 86 💬
400VOLIBRIS® (ambrisentan)[1] Ambrisentan[1] Ambrisentan 💬 [1] EDNRA 💬 [7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 86 💬
401VOLIBRIS™ tablets----[1] 86 💬
402Volixibat[1] Volixibat[2] Volixibat potassium ,
Volixibat 💬 		--[2] 93, 94 💬
403Volixibat (formely SHP626, LUM002 or SAR548304B)[1] Volixibat[2] Volixibat potassium ,
Volixibat 💬 		--[1] 94 💬
404Volixibat potassium[2] Potassium,
Volixibat		[3] Potassium ,
Volixibat potassium ,
Volixibat 💬 		--[2] 93, 94 💬
405VolixibatPharmaceutical Form: Capsule, hardINN or Proposed INN: volixibat potassiumCAS Number: 1431935-92-0Current Sponsor code: VLX, V-0027Other descriptive name: volixibatConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 5-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral useProduct Name: volixibatPharmaceutical Form: Capsule, hardINN or Proposed INN: volixibat potassiumCAS Number: 1431935-92-0Current Sponsor code: VLX, V-0027Other descriptive name: volixibatConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: Capsule, hardRoute of administration of the placebo: Oral use[1] Volixibat[2] Volixibat potassium ,
Volixibat 💬 		--[1] 93 💬
406VOLMAX*30CPR 4MG R.P.----[1] 3 💬
407Voltaren resinat----[1] 271 💬
408Voltarol SR----[1] 46 💬
409Voltarol SR (generics also available in the EU)----[1] 46 💬
410Voltrarol SR----[1] 46 💬
411Voluntary Peak Cough Flow Testing----[1] 2 💬
412VON WILLEBRAND FACTOR----[1] 288 💬
413Von Willebrand Faktor----[1] 288 💬
414Vonafexor[1] Vonafexor---[1] 218 💬
415Vonoprazan[1] Vonoprazan[1] Vonoprazan 💬 [2] ATP4A,
ATP4B 💬 		[3] Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬[3] 63, 97, 98 💬
416Voriconazole[1] Voriconazole[1] Voriconazole 💬 --[2] 60, 299 💬
417Vorinostat[1] Vorinostat[1] Vorinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[5] 65, 75, 96, 97, 156 💬
418Vorinostat (SAHA)[1] Vorinostat[1] Vorinostat 💬 [11] HDAC1,
HDAC10,
HDAC11,
HDAC2,
HDAC3,
HDAC4,
HDAC5,
HDAC6,
HDAC7,
HDAC8,
HDAC9 💬 		[20] ATP-dependent chromatin remodeling, Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Polycomb repressive complex, TGF-beta signaling pathway, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis 💬[1] 156 💬
419Vorsoritide----[1] 276 💬
420VORTIOXETINA BROMIDRATO----[1] 6 💬
421Vortioxetine[1] Vortioxetine[3] Vortioxetine ,
Vortioxetine hydrobromide ,
Vortioxetine hemihydrobromide 💬 		[7] HTR1A,
HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E,
SLC6A4 💬 		[6] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[2] 6, 127 💬
422Vortioxetine (tablet)[1] Vortioxetine[3] Vortioxetine ,
Vortioxetine hydrobromide ,
Vortioxetine hemihydrobromide 💬 		[7] HTR1A,
HTR3A,
HTR3B,
HTR3C,
HTR3D,
HTR3E,
SLC6A4 💬 		[6] Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬[1] 6 💬
423Vosoritide[1] Vosoritide[1] Vosoritide 💬 [1] NPR2 💬 [5] Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[3] 19, 195, 276 💬
424Vosoritide Injection[1] Vosoritide[1] Vosoritide 💬 [1] NPR2 💬 [5] Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 195 💬
425Vosoritide Injection [Voxzogo][1] Vosoritide[1] Vosoritide 💬 [1] NPR2 💬 [5] Hormone signaling, Oxytocin signaling pathway, Purine metabolism, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[2] 19, 276 💬
426Votoplam[1] Votoplam[1] Votoplam 💬 [1] HTT 💬 [2] Huntington disease, Pathways of neurodegeneration - multiple diseases 💬[1] 8 💬
427Votoplam (blinded)[1] Votoplam[1] Votoplam 💬 [1] HTT 💬 [2] Huntington disease, Pathways of neurodegeneration - multiple diseases 💬[1] 8 💬
428Votubia----[2] 34, 158 💬
429Voxzogo----[1] 276 💬
430VP 20624----[1] 65 💬
431VP-001----[1] 90 💬
432VPD-737----[1] 36 💬
433VPRIV----[1] 19 💬
434VPRIV - 400 U - POLVERE PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO----[1] 19 💬
435VPRIV 400 Units powder for solution of infusion----[1] 19 💬
436VPRIV ®,----[1] 19 💬
437VPRIV®----[1] 19 💬
438VR040----[1] 6 💬
439VR040/Aspirair® inhaler----[1] 6 💬
440VR496----[1] 299 💬
441VRG50635----[1] 2 💬
442VRP700----[1] 85 💬
443VRT-813077----[1] 299 💬
444VRT-826809----[1] 299 💬
445VRT-893661----[1] 299 💬
446VRT-893661 VRT-0893661----[1] 299 💬
447VSA003----[1] 79 💬
448VSA012----[1] 62 💬
449VSL#3----[4] 96, 97, 107, 291 💬
450VSL#3 (Original De Simone formulation)----[2] 96, 97 💬
451VSL#3®----[2] 96, 97 💬
452VSN16R----[1] 13 💬
453VSN16R 100mg----[1] 13 💬
454VT-001----[1] 66 💬
455VT-5006----[1] 6 💬
456VT7208----[1] 13 💬
457VTS-270----[1] 19 💬
458VTX-801[1] VTX-801---[1] 171 💬
459VTX-958----[1] 96 💬
460VTX002----[1] 97 💬
461VTX002 is not biologic----[1] 97 💬
462VTX002Pharmaceutical Form: Film-coated tablet----[1] 97 💬
463VTX2735----[1] 106 💬
464VTX3232----[1] 6 💬
465VTX958----[1] 96 💬
466VUM02 Injection----[1] 85 💬
467Vunakizumab[1] Vunakizumab---[4] 40, 49, 51, 271 💬
468Vunakizumab (IL-17A inhibitor)[1] Vunakizumab---[1] 49 💬
469Vutiglabridin[1] Vutiglabridin---[1] 6 💬
470Vutrisiran[1] Vutrisiran[2] Vutrisiran sodium ,
Vutrisiran 💬 		[1] TTR 💬 [1] Thyroid hormone synthesis 💬[1] 28 💬
471VX-118----[1] 299 💬
472VX-121----[1] 299 💬
473VX-121/TEZ/D-IVA----[1] 299 💬
474VX-121/tezacaftor/deutivacaftor[2] Deutivacaftor,
Tezacaftor		[2] Tezacaftor ,
Deutivacaftor 💬 		[1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
475VX-121/tezacaftor/deutivacaftorProduct Code: VX-121/TEZ/D-IVAPharmaceutical Form: Film-coated tabletINN or Proposed INN: VX-121CAS Number: 2374124-50-0Current Sponsor code: VX-121Other descriptive name: VX-121Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 10-INN or Proposed INN: tezacaftorCAS Number: 1152311-62-0Current Sponsor code: VX-661Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 50-INN or Proposed INN: deutivacaftorCAS Number: 1413431-07-8Current Sponsor code: VX-561Other descriptive name: D-IVAConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 125-Product Name: VX-121/tezacaftor/deutivacaftorProduct Code: VX-121/TEZ/D-IVAPharmaceutical Form: Film-coated tabletINN or Proposed INN: VX-121CAS Number: 2374124-50-0Current Sponsor code: VX-121Other descriptive name: VX-121Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 4-INN or Proposed INN: tezacaftorCAS Number: 1152311-62-0Current Sponsor code: VX-661Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-INN or Proposed INN: deutivacaftorCAS Number: 1413431-07-8Current Sponsor code: VX-561Other descriptive name: D-IVAConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 50-Product Name: VX-121/tezacaftor/deutivacaftorProduct Code: VX-121/TEZ/D-IVAPharmaceutical Form: Film-coated tabletINN or Proposed INN: VX-121CAS Number: 2374124-50-0Current Sponsor code: VX-121Other descriptive name: VX-121Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 4-INN or Proposed INN: tezacaftorCAS Number: 1152311-62-0Current Sponsor code: VX-[1] Tezacaftor[1] Tezacaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
476VX-147----[1] 222 💬
477VX-152----[1] 299 💬
478VX-272----[1] 299 💬
479VX-371----[2] 299, 340 💬
480VX-371 % 0,17% NaCl----[1] 340 💬
481VX-371 / 0.17% NaCl----[1] 340 💬
482VX-371 / 4,2% NaCl----[1] 340 💬
483VX-371 / 4.2% NaCl----[1] 340 💬
484VX-371 in hypertonic saline----[1] 299 💬
485VX-371 in saline----[1] 299 💬
486VX-407----[1] 67 💬
487VX-440----[1] 299 💬
488VX-445----[1] 299 💬
489VX-445 / TEZ / IVA----[1] 299 💬
490VX-445 / TEZ / IVA FDC----[1] 299 💬
491VX-445 /TEZ/IVA----[1] 299 💬
492VX-445/TEZ/IVA----[1] 299 💬
493VX-509----[1] 46 💬
494VX-522 mRNA therapy----[1] 299 💬
495VX-561----[1] 299 💬
496VX-561 (CTP-656)----[1] 299 💬
497VX-581----[1] 299 💬
498VX-634----[1] 231 💬
499VX-659----[1] 299 💬
500VX-659/ TEZ/IVA----[1] 299 💬
501VX-659/TEZ/IVA----[1] 299 💬
502VX-659/Tezacaftor/Ivacaftor[2] Ivacaftor,
Tezacaftor		[2] Ivacaftor ,
Tezacaftor 💬 		[1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
503VX-661----[1] 299 💬
504VX-661 / VX-770----[1] 299 💬
505VX-661 Plus Ivacaftor Combination[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
506VX-661, VRT-893661----[1] 299 💬
507VX-661/Ivacaftor[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
508VX-661/ivacaftor (VX-770) 100mg/150 mg[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
509VX-661/ivacaftor 100 mg/ 150 mg[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
510VX-661/ivacaftor 100mg/150 mg[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
511VX-661/ivacaftor 100mg/150mg[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
512VX-661/ivacaftor 50 mg/ 75 mg[1] Ivacaftor[1] Ivacaftor 💬 [1] CFTR 💬 [9] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Phagocytosis, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299 💬
513VX-661/VX-770----[1] 299 💬
514VX-661/VX-770 (TEZ/IVA)----[1] 299 💬
515VX-668----[1] 231 💬
516VX-670----[1] 113 💬
517VX-702[1] VX-702---[1] 46 💬
518VX-745----[1] 8 💬
519VX-765----[1] 106 💬
520VX-77----[1] 299 💬
521VX-770----[2] 299, 340 💬
522VX-770, VRT-8130077----[1] 299 💬
523VX-770, VRT-813077----[1] 299 💬
524VX-809----[1] 299 💬
525VX-809 & VX-770----[1] 299 💬
526VX-809 / VX-770----[1] 299 💬
527VX-809, VRT-826809----[1] 299 💬
528VX-809/VX-770----[1] 299 💬
529VX-814----[1] 231 💬
530VX-828----[1] 299 💬
531VX-864----[1] 231 💬
532VX147----[1] 222 💬
533VX15/2503----[2] 8, 13 💬
534VX864----[1] 231 💬
535VY-AADC01----[1] 6 💬
536VY-AADC02----[1] 6 💬
537VYKAT XR----[1] 193 💬
538Vyndamax (tafamidis 61mg)[1] Tafamidis[2] Tafamidis ,
Tafamidis meglumine 💬 		[1] TTR 💬 [1] Thyroid hormone synthesis 💬[1] 28 💬
539Vyndaqel----[1] 28 💬
540VYNDAQEL - 20 MG - CAPSULA MOLLE - USO ORALE - BLISTER (PVC/ALU) 30 CAPSULE----[1] 28 💬
541Vyndaqel 20 mg soft capsule----[1] 28 💬
542Vyndaqel 20mg soft capsule----[1] 28 💬
543VYNT-0126----[1] 156 💬
544Vyondys 53----[1] 113 💬